Sila Realty Trust, Inc. (NYSE: SILA)

Sila Realty Trust, Inc. is an internally managed real estate investment trust that focuses on acquiring high quality healthcare facilities across the continuum of care. The company was formed in 2013 and elected to be taxed as a REIT under the Internal Revenue Code. As of December 31, 2024, it owned 135 real estate healthcare properties and two undeveloped land parcels. Its portfolio includes inpatient rehabilitation centers, behavioral health facilities, skilled nursing properties, and other care sites. Sila Realty Trust may also make equity or debt investments in other real estate entities when opportunities align with its strategy. The company seeks to acquire properties that are essential to the daily operations of its tenants and are located in markets with strong demographic trends. Sila Realty Trust employs an internal team to manage acquisitions, asset management, and disposition activities. As a REIT, it must distribute at least 90% of its taxable income to shareholders to maintain its tax status.

The company generates revenue primarily from rental income collected on its properties under long term net leased agreements. These leases typically include annual or periodic rent increases and are structured to pass operating expenses to the tenant. In addition to rent, Sila Realty Trust earns interest income from mezzanine loans it has originated for the development of healthcare projects. The mezzanine loans originated in 2024 have committed amounts of twelve million five hundred forty three thousand dollars and five million dollars respectively. These loans are scheduled to mature in November 2029 and funding is expected to begin in 2025. Property sales during the year generated gross proceeds of eighteen million seven hundred thousand dollars and net proceeds of seventeen million seven hundred five thousand dollars. The company may also realize gains from the occasional sale of properties that no longer meet its investment criteria. Interest income from cash balances and other investments contributes a smaller share of total revenue. The company also earns modest income from interest on cash balances, short term investments, and other liquid assets.

Sila Realty Trust operates in a competitive healthcare real estate market where it faces rivals such as other public REITs, private equity funds, and institutional investors that pursue similar assets. Its competitive advantages stem from an internally managed structure that reduces reliance on external advisors, a focus on creditworthy tenants that often carry investment grade ratings, and a lease strategy that emphasizes long term contracts with built in rent escalations. The company also seeks geographic and tenant diversification to reduce exposure to any single market or operator. These factors help Sila Realty Trust maintain stable cash flows and support its goal of delivering regular distributions to shareholders. It also monitors tenant credit through review of publicly available financial statements, industry reports, and rent collection timeliness. The management team believes that its focus on long term net leased structures reduces turnover and enhances predictability of cash flows.

The company's tenants are healthcare operators that range from large national chains to regional and local providers. As of December 31, 2024, the largest single tenant was Post Acute Medical, LLC and its affiliates, which contributed approximately 14.9% of rental revenue for the year. Other important tenants include skilled nursing firms, rehabilitation centers, and behavioral health service providers. Sila Realty Trust does not disclose a full list of tenant names beyond the major concentration noted, but its portfolio is designed to serve facilities that provide essential care to patients across the United States. The portfolio includes properties leased to operators of inpatient rehabilitation, behavioral health, and skilled nursing facilities across multiple states. No other single tenant accounted for 10% or more of rental revenue in 2024 besides the Post Acute Medical group.